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RESEARCH ARTICLE
Characterization and in ovo vascularization of a 3D-printed
hydroxyapatite scaffold with different extracellular matrix coatings
under perfusion culture
Floriana Burgio1,‡, Natalie Rimmer1,‡, Uwe Pieles1, Johanna Buschmann2,§,¶ and Marina Beaufils-Hugot1,*,§,¶
ABSTRACT
For the fabrication of appropriate bone tissue-engineered constructs
several prerequisites should be fulfilled. They should offer long-term
stability, allow proper cell attachment and proliferation and
furthermore be osteoinductive and easy to be vascularized. Having
these requirements as background, we fabricated a novel porous
3D-printed hydroxyapatite (HA) scaffold and treated it with oxygen
plasma (OPT). MG-63 pre-osteoblast-seeded bone constructs
allowed good cell attachment and proliferation, which was even
better when cultivated in a perfusion flow bioreactor. Moreover, the
deposition of extracellular matrix (ECM) on the otherwise inorganic
surface changed the mechanical properties in a favourable manner:
elasticity increased from 42.95±1.09 to 91.9±5.1 MPa (assessed
by nanoindentation). Compared to static conditions, osteogenic
differentiation was enhanced in the bioreactor, with upregulation of
ALP, collagen I and osteocalcin gene expression. In parallel
experiments, primary human bone marrow mesenchymal stromal
cells (hBMSCs) were used and findings under dynamic conditions
were similar; with a higher commitment towards osteoblasts
compared to static conditions. In addition, angiogenic markers
CD31, eNOS and VEGF were upregulated, especially when
osteogenic medium was used rather than proliferative medium. To
compare differently fabricated ECMs in terms of vascularization,
decellularized constructs were tested in the chorioallantoic
membrane (CAM) assay with subsequent assessment of the
functional perfusion capacity by MRI in the living chick embryo.
Here, vascularization induced by ECM from osteogenic medium led
to a vessel distribution more homogenous throughout the construct,
while ECM from proliferative medium enhanced vessel density at the
interface and, to a lower extent, at the middle and top. We conclude
that dynamic cultivation of a novel porous OPT HA scaffold with
hBMSCs in osteogenic medium and subsequent decellularization
provides a promising off-the-shelf bone tissue-engineered construct.
KEY WORDS: Perfusion culture, Ceramic, Elastic modulus,
Osteogenesis, Angiogenesis, CAM assay
INTRODUCTION
In maxillofacial and orthopaedic surgery, repair and regeneration of
bone defects caused by trauma, tumour excision or infection is daily
business and is a central clinical goal. To treat bone tissue loss,
the development of novel orthopaedic strategies based on tissue
engineering approaches has progressed considerably over the last
four decades (Langer et al., 1990; Venkatesan and Kim, 2010;
Boland, 2017; Forrestal et al., 2017; Hosseinpour et al., 2017;
Khakestani et al., 2017; Kim et al., 2017; Janko et al., 2018).
In particular, bone tissue engineering aims to regenerate damaged
tissues by combining osteogenic cells with highly porous
biomaterials, which act as templates for tissue regeneration, and
subsequent osteointegration (Amini et al., 2012; Boland, 2017).
Among the different kinds of biomaterials (polymers, ceramics and
composite materials), calcium phosphate ceramics are widely
investigated thanks to excellent biocompatibility, bioactivity and
osteoconductivity. In particular, hydroxyapatite (HA)-based scaffolds
(Lee et al., 2013; Ha et al., 2015; Dang et al., 2016) are of
considerable interest, since HA is the major inorganic component of
natural bone (Nandi et al., 2010). One major drawback of pure HA
scaffolds, however, is their brittleness (Shi et al., 2014; Owen et al.,
2017), which has been overcome by various approaches, such as
composites with polymers (Roeder et al., 2008; Cox et al., 2015;
Zeng et al., 2018) or by the deposition of extracellular matrix (Sadr
et al., 2012), which increases the elasticity of the materials.
Besides gas or chemical foaming (Kucharska et al., 2012), salt
leaching (Cao and Kuboyama, 2010; Stoppato et al., 2013) or
thermally induced phase separation (Hutmacher, 2000), 3D printing
is a suitable and well established technique to produce porous HA
biomaterials, as it provides tailored templates that are able to enhance
cell adhesion, proliferation, differentiation and neovascularization
(Leukers et al., 2005; Bose et al., 2013, 2018; Forrestal et al., 2017;
Shaunak et al., 2017; Zhang et al., 2017a,b; Zeng et al., 2018).
3D printing of HA has been reported to be successful for
craniomaxiofacial regeneration (Gaviria et al., 2017), among others
(Heller et al., 2016).
To better reproduce an in vivo-like environment, the use of 3D
cell-seeded scaffolds cultivated in a perfusion bioreactor system has
been shown (i) to improve cell seeding efficiency (Gardel et al.,
2014), (ii) to maintain a uniform distribution of viable cells
throughout scaffolds (Lee et al., 2017) and (iii) to overcome the
limited mass exchange of nutrients and oxygen observed under
static conditions (Bancroft et al., 2002; Wendt et al., 2003; Kashte
et al., 2017). Finally, bone tissue engineered scaffolds cultured in a
perfusion bioreactor showed a better in vivo performance compared
to statically cultivated scaffolds (Yeatts et al., 2014).Received 27 March 2018; Accepted 28 September 2018
1School of Life Sciences, Institute for Chemistry and Bioanalytics (ICB),
Gründenstrasse 40, CH-4132 Basel, Switzerland. 2University Hospital Zürich
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Hence, the hypotheses of our study were that:
i. ECM deposition enhances elastic properties of a 3D-printed
HA scaffold,
ii. perfusion culture improves cell infiltration into the macro-
and micro-pores of the scaffold and
iii. ECM deposition enhances vascularization of 3D-printed HA
scaffold.
RESULTS
Scaffold architecture, microstructure and mechanical
properties
Macroscopic and SEM images of porous HA scaffolds produced by
a 3D printing method and sintered at 1425°C are shown in Fig. 1. In
addition to the printed, geometric macroporous structure with pores
ranging from 300 to 600 µm (Fig. 1A,B), a microporous structure,
with pores of 10–15 µm, was observed inside the material at higher
magnification (Fig. 1C). Upon deposition of ECM by hBMSCs, the
elastic modulus, as assessed by nanoindentation, increased for
the non-devitalized scaffold from 42.95±1.09 (cell-free) to 91.9±
5.1 MPa (cell-seeded).
Standard compression tests resulted in an elastic modulus of
the bulk scaffold of 14.2±7.9 MPa (cell-free) and 19.3±2.9 MPa
(cell-seeded).
Cell seeded 3D-printed HA scaffolds: static versus dynamic
culture
The proliferation of MG-63 osteoblast-like cells seeded on 3D-
printed porous HA scaffolds after 18 h, 3, 7, 14 and 28 days of
culture under static (24-well plate) and dynamic (perfusion
bioreactor) conditions was evaluated. An MTT assay was used
as a qualitative method to visualize cell viability. After 18 h of cell
seeding under static conditions, cell distribution was not
homogeneous, and only a few cells were present at the bottom
part of the scaffold, as shown in Fig. 2A. In contrast, under
dynamic conditions, there were more cells and cell distribution
was more homogeneous, with cells covering the whole surface of
the scaffold. Based on the analysis of the DNA content, cell
number was assessed with or without OPT of the HA scaffolds
(Fig. 2B).
This cell quantification was performed 18 h, 3, 7, 14 and 28 days
after seeding, and static and dynamic conditions were compared. In
static cultures, the number of MG-63 cells in the constructs did not
significantly increase after 28 days of culture; even after hydrophilic
surface modification (i.e. with OPT). In contrast, under perfusion
culture, a three- to fourfold increase in cell number was observed
from 18 h to 28 days of culture. Moreover, the cell number reached a
plateau after 7 (threefold) and 14 (fourfold) days of culture,
respectively, with or without OPT. Cell attachment and spreading
were assessed by SEM analysis (Fig. 2C). MG-63 cells grown for
28 days under static conditions (Fig. 2C, first column) adhered and
grew on the HA matrix but left some uncovered areas. In contrast,
the osteosarcoma cells grown under perfusion culture (Fig. 2C,
second column) showed a dense cell multilayer, with a more
homogeneous cell distribution, already 7 days after cell seeding.
In similar perfusion culture conditions, hBMSCs exhibited even
denser cell coverage, already 18 h after cell seeding (Fig. 2C, third
column). After 28 days of culture a homogenous and continuous
coating made of cells but also of secreted ECM was observed in the
histological sections (Fig. 2C, third row).
Histological analysis was performed to analyse tissue formation
and cell invasion into the material under static and dynamic
conditions after 28 days of culture. Under static conditions, MG-63
cells generated a thin tissue layer (35 µm) at the surface of the pores
of HA scaffolds, with limited evidence of cell ingrowth inside
the material (Fig. 2C, third row on the left). Under dynamic
conditions, MG-63 cells generated a similar tissue at the surface of
the 3D-printed ceramic, but was denser in terms of cells coating, now
also invading the inner part of the biomaterial (Fig. 2C, third row in
the middle).When hBMSC cells were cultivated with perfusion flow
under the same conditions, the tissue thickness reached 250 µm
(sevenfold increase) after 28 days and cell infiltration into the
microstructure of the biomaterial was even denser in comparison to
MG-63 cells (Fig. 2C, third row on the right).
Osteogenic differentiation of MG-63 cells and hBMSC
MG-63 cells
The gene expression of alkaline phosphatase (ALP), collagen I
and osteocalcin was analyzed by PCR. Markers of osteoblastic
differentiation, namely ALP and osteocalcin, showed a peak of gene
expression at day 7 under dynamic (+OPT) conditions and higher
expression in dynamic conditions as compared to static culture
(Fig. 3). Collagen I mRNA expression was much higher with
perfusion flow than in static conditions after 28 days of culture.
Higher expression of osteocalcin by MG-63 cells in dynamic
perfusion culture was qualitatively confirmed at the protein level at
28 days of culture by immunofluorescence. More functionally,
under perfusion flow, ALP activity by MG-63 increased from day 3
to day 14 to reach a peak after 2 weeks of culture. ALP activity of
MG-63 cells cultured on oxygen-plasma pre-treated scaffolds in
dynamic conditions reached the plateau value at day 7.
hBMSCs
hBMSCs cultured under perfusion exhibited strong osteoblastic
differentiation with increased gene expression of markers such as
ALP, collagen I and osteocalcin when compared to undifferentiated
hBMSCs (Fig. 4).
Fig. 1. 3D printed hydroxyapatite scaffold with defined macroporosity. Scale bars: 0.5 cm (A), 500 µm (B) and 5 µm (C).
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Fig. 2. Cell attachment and proliferation on 3D-printed HA scaffold under static versus dynamic conditions. (A) MTT staining after 18 hours of cell
seeding under static (left) and dynamic (right) conditions. (B) Cell number based on DNA content of cells seeded on untreated or oxygen-plasma treated
(OPT) scaffolds for up to 28 days of culture under static or dynamic conditions. (C) SEM images of MG-63 cells cultivated on 3D-printed HA scaffolds
after 18 h, 7 and 28 days of culture in static (left column) and dynamic conditions (middle column) and of hBMSCs cultivated under dynamic conditions
(right column), scale bar: 10 μm. Lower panels show histological H&E stained sections of corresponding cell-seeded scaffolds after 28 days (scale bars:
500 μm).
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Perfusion capacities of decellularized scaffolds in the CAM
assay
Angiogenic markers genes, such as VEGF, CD31 and eNOS
exhibited significantly higher gene expression levels (VEGF,
P<0.0001; CD31, P=0.0078; eNOS, P<0.0001) with
differentiation medium (DI) than with proliferative medium
(Fig. 5A–C).
MRI of the living chicken embryos with onplanted decellularized
scaffolds as well as uncoated HA scaffolds in the windowed egg
(Fig. 5D) was performed to analyse perfusion capacity of the
constructs (functional vessels). Although only at the interface,
statistically significant differences were found between osteogenic
medium and proliferation medium (Fig. 5E). The two different
ECMs attracted vessels to a significantly higher extent into the
construct compared to cell-free HA.
DISCUSSION
In this study, we characterized a novel porous 3D HA scaffold
aimed at bone tissue engineering (Fig. 1). First, the 3D HA scaffold
was oxygen-plasma treated (+OPT) and seeded with MG-63 pre-
Fig. 3. Differentiation of MG-63 human osteoblast-like cells cultured on 3D-printed porous HA scaffolds under static versus dynamic conditions. Real-
time PCR analysis of (A) ALP (left) and ALP activity (right); (B) Collagen I and (C) Osteocalcin expressed by MG-63 cells under static and dynamic conditions after
3, 7, 14 and 28 days of culture, and corresponding immunofluorescence staining after 28 days of culture under static and dynamic conditions. Scale bars: 20 µm.
Fig. 4. Real-time PCR analysis of bone-associated genes expressed by hBMSC cells cultured in dynamic condition on 3D-porous HA scaffolds.
(A) ALP. (B) Collagen I. (C) Osteocalcin. Cultured in proliferation medium or differentiation medium (DI).
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osteoblasts. Cell-seeded scaffolds±OPTwere either cultivated under
static conditions or in a perfusion flow bioreactor under dynamic
conditions. Compared to static cultivation, dynamic cultivation
improved cell attachment and proliferation of MG-63 cells
significantly (Fig. 2). Moreover, dynamic cultivation increased
mRNA expression of typical osteogenic marker genes like ALP,
collagen I or osteocalcin compared to static cultivation (Fig. 3). 3D
HA scaffolds especially, when treated with OPT, triggered the
desired differentiation in MG-63 pre-osteoblasts as shown by a
significant increase of ALP expression on day 7. Of note, ECM
deposition also improved the mechanical properties of the scaffold
with an increased Young’s modulus compared to cell-free scaffolds.
Cell seeding and differentiation
For the initial tests, MG-63 cells served well as an in vitro
model cell line. However, due to their low capacity for calcium
deposition and their lack for osteoblastic function, their different
proliferation rate, ALP activity and ECM formation, human
primary bone-marrow derived mesenchymal stem cells (hBMSCs)
were used for further optimization of the cell-enhanced
biomaterial. Hence, human BMSC-seeded OPT 3D HA
scaffolds were cultivated under dynamic conditions. In order to
support osteogenic differentiation, osteoinductive medium (DI,
differentiation induction) was used and compared to proliferative
medium. As expected, osteogenic marker genes were expressed
significantly more in osteogenic medium compared to proliferative
medium (Fig. 4). In addition, angiogenic marker genes like VEGF,
CD31 and eNOS were significantly increased in DI medium
(Fig. 5A–C). As angiogenesis always precedes osteogenesis and
only both processes together ensure true bone formation
(Scherberich et al., 2010; Wang et al., 2010; Wu et al., 2017),
we tested the two scaffolds after decellularization with regards to
vascularization. In other words, the two different ECMs, produced
either by hBMSCs in proliferative or osteogenic culture medium,
Fig. 5. Real-time PCR analysis angiogenesis-related genes expressed by hBMSC cells cultured under dynamic condition on 3D-porous HA
scaffolds and typical angiogenesis assay. The CAM assay allows in ovo vascularistion of biomaterials planted on the surface. (A–C) Manifold gene
expression of (A) VEGF, (B) CD31and (C) eNOS cultured in proliferation medium (grey bars) or osteogenic differentiation medium (DI, black bars).
(D) Windowed egg at incubation day ID7 when HA scaffolds were onplanted (left) and vascularized HA scaffold coated with ECM from osteoinductive
medium at ID14 after 1 week on the CAM (right). (E) Relative relaxation rates as assessed in the MRI of HA scaffolds decorated with ECM produced by cells
cultivated in osteogenic medium with differentiation induction (black bars) or in proliferative medium (light grey bars) and of uncoated HA scaffolds (dark grey
bars). For the precise composition of the two culture media, see Materials and Methods section. A scheme (on top) represents the different regions of the
scaffold (surface, middle and interface) of an egg.
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respectively, were compared with regards to their angiogenic
potential in the CAM assay (Fig. 5D). Although not significantly
different, there was a trend for higher vessel density and perfusion
capacity in the upper part of the vascularized scaffolds evoked by
the ECM fabricated in osteogenic medium (Fig. 5E). In contrast,
ECM coating from cultures in proliferative medium had a higher
perfusion capacity at the interface than at the middle or top of the
scaffolds.
Static versus dynamic cultivation
It has been shown in several studies that dynamic cultivation of stem
cells enhances osteogenesis. For example, Silva and colleagues
reported the beneficial effect on adipose-derived stromal cells (ASCs)
if seeded on a bioactive glass foam and cultivated in a perfusion
bioreactor in terms of osteogenesis (Silva et al., 2014). Moreover,
enhancement of human ASCs’ proliferation and differentiation
towards osteoblasts was also confirmed when cells were seeded on a
blend of corn starch and polycaprolactone (Rodrigues et al., 2012). For
the hBMSCs used in our study, it was also reported that osteogenesis is
supported by perfusion flow conditions – even for a short time of
perfusion such as 2 h (Filipowska et al., 2016). Hence, our findings
stand in accordance with results obtained from many different systems
includingmesenchymal stromal cells seeded on a scaffoldmaterial and
exposed to dynamic culture conditions in form of perfusion flow.
Mechanistic aspects beneath the finding that perfusion flow may
trigger osteogenesis lie in the mechanobiology of cells; shear stress
deforming the cells is a typical trigger (McCoy and O’Brien, 2010;
Yourek et al., 2010; Bodle et al., 2011; Stavenschi et al., 2017) as well
as enhanced cell-to-cell communication due to closer proximity of the
cells evoked by the perfusion (Tang et al., 2010). Moreover, as clearly
shown in our study, perfusion regimen leads to a dense ECM
deposition, especially for hBMSCs, and thus increases the scaffold’s
elastic modulus twofold. Different elasticity of the scaffold
encountered by the cells leads to an enhanced osteogenesis (Engler
et al., 2006; Zhang et al., 2017a,b). In summary, dynamic cultivation
evokes changes on different levels – directly by the deformation of the
cells exposed to shear stress, but also indirectly, by enhancing
proliferation and increasing cell density and in doing so affecting cell-
to-cell interactions, and finally by changing the ECM depo- and
compositions and, thereby, modifying the mechanical properties of the
scaffold material during the time of the experiment.
Angiogenic potential
Angiogenesis is a main issue in bone tissue engineering because it
has been shown that many bone grafts constructed in vitro do not
perform satisfactorily in vivo – necrotic parts caused by insufficient
vascularization may be faced. Many attempts have been undertaken
to overcome this problem (Laschke et al., 2007; Scherberich et al.,
2010; Helmrich et al., 2013). Strategies like VEGF application,
arterio-venous loop construction (Manasseri et al., 2007), micro-
tissue based bottom-up approaches (Declercq et al., 2013) or
implementation of vasculogenic cells (Amini et al., 2016) have been
undertaken. Here, we focused on the effect of ECM deposition on
vascularization when the decellularized ECM-coated HA was
planted onto the CAM. The effect of ECM deposition on
synthetic polymers has been shown to overcome limited
biological functionality (Sadr et al., 2012; Bourgine et al., 2017).
The CAM assay is an easy and cheap in vivo (in ovo) assay, where
the perfusion capacity in biomaterials can be easily assessed byMRI
(Kivrak Pfiffner et al., 2014).
In order to answer whether or not two differently fabricated ECMs
deposited by BMSCs that have been cultivated under perfusion, but
in two different culture media (either in osteogenic or in proliferative
medium), would have any impact on the functional vascularization of
those constructs compared to cell-free scaffolds, we cultivated the
decellularized constructs for 1 week on the CAM and assessed the
relative relaxation rates in three different regions of the construct by
MRI (at the interface, in the middle and at the surface). mRNA
expression levels of VEGF and eNOS were significantly higher in
hBMSCs (around 5- and 2.5-fold, respectively) when cultivated for 4
weeks in osteogenic medium rather than in proliferation medium
(Fig. 5A–C). Nevertheless, these changes in gene expression level
did not significantly impact the osteogenic medium-related ECM
containing this information. In contrast, at the interface to the CAM,
there was a higher perfusion capacity found for ECM coating from
proliferative rather than osteogenic medium. Compared to cell-free
scaffolds, however, the ECM-coated scaffolds (from both media)
attracted significantly more vessels from the CAM into the 3D-
printed HA and this resulted in a significantly higher perfusion
capacity (Fig. 5D,E). Although the constructs were completely
decellularized, the two ECMs obtained differed in their angiogenic
potential compared to the cell-free scaffolds, probably caused
by a higher elastic modulus of the surface as determined by
nanoindentation, facilitating the vessels to grow into the ECM-coated
pores. Interestingly, reports on improved biocompatibility and
increased osteoblastic differentiation of newly seeded pre-
osteoblasts on ECM-coated scaffolds have reported upregulation of
typical osteoblastic genes (Kim et al., 2018). However, the influence
of ECM-coating by hBMSCs with an upregulation of both typical
osteogenic and angiogenic genes, respectively, on in vivo functional
performance (perfusion capacity of functional vessels) have not been
reported so far. The observed effect is interesting in terms of bone
grafts inducing vessel-gradients, offering osteochondral interface as a
potential application (Camarero-Espinosa and Cooper-White, 2017).
In summary, 3D-printed HA bone grafts can be instructed to attract
vessels in different ways by decoration with specifically generated
ECMs, and ECM coating leads to a higher in ovo perfusion capacity
compared to cell-free HA scaffolds.
Limitations
Although we applied the two ECM-coated and ECM-free scaffolds
in vivo and assessed functional perfusion capacity in ovo, the CAM
assay is restricted by a time window of 7 days where biomaterials
can be vascularized. This is a comparatively short period when
compared to other pre-clinical animal models that allow study of
vascularization over a longer time. Although we found a different
vascularization pattern for the two ECMs only at the interface,
ECM coating enhanced the perfusion capacity in ovo significantly
when compared to ECM-free analogues. Also, we only tested two
different culture media and their corresponding ECMs, which
might be interesting when enlarged – with the addition of different
types of media to test if further vascularization patterns may be
realized.
CONCLUSIONS
We conclude that cultivation of human BMSCs on an OPT 3D HA
scaffold intended for bone tissue engineering is favoured in
dynamic conditions over static conditions, because osteogenesis is
enhanced and triggered in vitro. Moreover, dynamic cultivation in
osteogenic medium rather than proliferative medium upregulates
typical angiogenic marker genes and may help to direct succeeding
in vivo vascularization of the decellularized ECM-coated scaffold
towards a fully vascularized and functional graft – as shown by our
experiments in the CAM assay.
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MATERIALS AND METHODS
An overview of the experimental design is given in Fig. 6, including
experimental steps to realize a scaffold with tailored osteoinductive and
angiogenic properties.
Preparation of the HA scaffold by 3D printing
Scaffolds were produced at the Institut für Medizinal und
Analysetechnologien (IMA) of the Fachhochschule Nordwestschweiz
(FHNW, Muttenz, Switzerland). Discs (10 mm diameter, 4 mm thick) were
produced from HA powder (Medicoat AG, Mägenwil, Switzerland, MF/09-
4964-03) with a 3D-printing system (3D-Printer Z-510, Z-Corporation).
During the printing process, 10wt. % citric acid and 15wt. % phosphoric acid
were added to the powder as a binder. In order to consolidate the specimens,
sintering of ceramic materials was performed at 1425°C for 2 h (Carbolite
RHF 1500). Scaffolds had an internal porosity of 61%,which was assessed by
Archimedes’ principle (Taylor et al., 1999), and an internal pore dimension
ranging from 300 to 600 μm (macropores) and from 10 to 15 µm
(micropores). The pore size was assessed in SEM images, with n=50.
Cell culture and scaffold seeding
MG-63 human osteoblast-like cells are osteosarcoma cells and were a
kind gift from René Prétôt [Laboratory of Toxicology, Institut für
Chemie und Bioanalytik (ICB), Fachhochschule, Muttenz, Switzerland].
MG-63 cells were cultured in Dulbecco’s Modified Eagle Medium high
glucose (DMEM; Sigma-Aldrich, D6429) containing 1% penicillin/
streptomycin/glutamine (Life Technologies, Invitrogen, 10378-016)
supplemented with 10% fetal bovine serum (FBS; Gibco), 1% MEM
non-essential amino acids (Life Technologies, 11140-035) and kept at
37°C and 5% CO2.
hBMSC primary cells were obtained from eight healthy donors aged
36–54 years from different marrow cavities during routine orthopaedic
surgery in accordance with the local ethical committee (University
Hospital Basel) as previously described (Braccini et al., 2005) and
cultured in α-Modified Eagle’s Medium containing 10% FBS, 100 mM
HEPES buffer solution, 1 mM sodium pyruvate, 100 U/ml penicillin,
100 µg/ml streptomycin and 292 µg/ml L-glutamine (Gibco), 100 nM
dexamethasone (Sigma-Aldrich), 100 µM ascorbic acid 2 phosphate and
5 ng/ml fibroblast growth factor-2 (FGF-2; R&D Systems). The media were
changed twice a week. Upon 80-90% cell confluency, cells were detached
(0.5 g/l Trypsin/0.2 g/l EDTA, Invitrogen), and cell number and viability
were assessed in a Neubauer chamber with trypan-blue dye exclusion test.
Discs of porous HA scaffolds (10 mm diameter and 4 mm thick) were
sterilized by oxygen-plasma treatment (OPT) for 2 min [Harrick Plasma;
Expanded Plasma Cleaner (PDC-002)] according to the manufacturer’s
instructions. Scaffolds without OPT were sterilized by autoclaving at 121°C
and 15 psi for 15 min. The two sterilization processes were necessary
because OPT was, besides the surface treatment, also a sterilization process,
while for the non-OPT treated samples, another sterilization process
(autoclaving) had to be used.
Static cultivation
Scaffolds used for static conditions were pre-soaked in proliferative culture
medium overnight at 37°C and 5%CO2. Then they were placed one per well
in an agarose-coated 24-multiwell plate to avoid any plastic cell adherence.
1×106 cells were slowly dispersed over the top of each scaffold within a
small volume (50 µl) of maintenance medium. After seeding, the cell
constructs were incubated for 2.5 h to allow initial cell adhesion, before the
addition of 1.5 ml of complete medium per well.
Dynamic cultivation (perfusion flow)
For 3D culture, HA scaffolds were seeded by 1×106MG-63 or hBMSC cells
and placed into a perfusion bioreactor device (U-CUP, Cellec Biotek AG)
according to the manufacturer’s instructions. Superficial velocity of 4.7 ml/
min was applied for the first 18 h to allow initial cell adhesion, then changed
to 0.47 ml/min until 28 days. In the meantime, 1×106 cells were aliquoted,
collected and stored at−20°C in order to be used as DNA or RNA reference.
After a total of 3 days for cell expansion, proliferation medium was
replaced by differentiation medium by adding 100 µM ascorbic acid
2-phosphate (Sigma-Aldrich), 10 mM β-glycerophosphate (BGP),
100 nM dexamethasone (Millipore) and 10 nM 1,25-Dihydroxyvitamin
D3 (Sigma-Aldrich) for MG-63 cells, or by adding 10 mM BGP and
10 nM 1,25-Dihydroxyvitamin D3 for hBMSC cells. Ten mM BGP was
used according to established protocols (Zuk et al., 2002), it has to be
noted, however, that free phosphate ion concentration might vary during
cultivation (Schäck et al., 2013). The differentiation medium was replaced
twice a week. After 18 h, 3, 7, 14 and 28 days of culture, the cell constructs
were used for assays of cell viability and proliferation, DNA content, cell
adherence, and osteoblast differentiation as described in the following
paragraphs (n=4 for each assay). After cutting each scaffold in two, three or
four parts with a sterilized scalpel, each piece of scaffold was weighed and
characterized to determine cell seeding efficiency, cell proliferation and
differentiation.
Fig. 6. Overview of experimental design. Steps to
tailor the 3D-printed ceramic scaffold (left) and
methods used, as well as the parameters assessed at
each step (right).
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Cell viability
To observe cell viability and distribution on the scaffold, the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was
performed. The MTT assay is a measure of metabolic activity. According
to each time point designed for the MTT assay (n=4 for each time point),
scaffolds were taken out from the 24-multiwell plate (static condition) or
from the U-CUP perfusion bioreactor (dynamic condition). Briefly, each
scaffold was transferred into a new 24-multiwell plate and incubated into
1 ml of complete medium mixed with 100 µl of MTT reagent (12 mM).
Following 3 h of incubation at 37°C and 5% CO2, each scaffold was rinsed
and stored in 1 ml of 1× PBS and observed using an inverted microscope
(Zeiss Axiovert 40 CFL).
Cell proliferation assay
The number ofMG-63 or hBMSC cells that attached and grew on the scaffold
was determined by quantifying the total DNA content. Briefly, each sample
was incubated in 500 µl of phosphate buffered extraction solution (PpK) at
56°C for 16 h. To avoid any DNA-ceramic binding, the PpK solution was
obtained by supplementing a proteinase K solution (pK; prepared by adding
proteinase K 1 mg/ml, pepstatin A 19 µg/ml, EDTA 1 mM, iodoacetamide
1 mM, TRIS 50 mM to distilled water; Sigma-Aldrich) with potassium
phosphate salts (HK2PO4 and H2KPO4; Fluka, Sigma-Aldrich) (Piccinini
et al., 2010). DNA quantification was performed using the Quant-iT™
PicoGreen® dsDNA Assay kit (Invitrogen) following the manufacturer’s
protocol. After incubation, the specimens were centrifuged at 10,000 g, 4°C
for 5 min. 5 µl of supernatant from each sample was added to 195 µl of
PicoGreen® reagent working solution in a 96-well black flat bottom plate. The
analyses were carried out by measuring the fluorescence with a FlexStation™
3 Microplate Reader (Molecular devices, USA), and the data were analysed
using SoftMax Pro software. Excitation and emission wavelengths were
485 nm and 535 nm, respectively. A calibration curvewas prepared in parallel
by diluting a lambda standard DNA (1 µg/ml) to different concentrations
(0, 50, 200, 600 and 1000 ng/ml). From the fluorescence obtained for the
samples, the 0-value was subtracted and then divided through the slope of the
standard curve (R2=0.999). Each sample and standard was measured in
triplicate. The total number of cells per scaffold was determined by dividing
the total DNA amount by the DNA amount per cell. The latter was obtained
by keeping 2million of cells separate (as a reference) and determination of the
DNA amount for these non-seeded cells.
ALP assay
ALP activity was quantified using an enzymatic assay based on the hydrolysis
of p-nitrophenyl phosphate (pNP-PO4, colourless) to p-nitrophenol (pNP,
yellow) (Kim et al., 2012). ALP activity was quantified by the SensoLyte®
pNPP Alkaline Phosphatase Assay Kit (Anaspec). Working solutions were
prepared according to the manufacturer’s protocol. Each scaffold was washed
twice with 1× assay buffer, crushed into small pieces and incubated in 500 µl
lysis buffer [0.2% (v/v) Triton 100x] at 4°C for 10 min. After incubation, the
samples were centrifuged at 2500 g, 4°C for 5 min to remove scaffold debris.
50 µl of supernatant from each sample containing alkaline phosphatase was
mixed with 50 µl of pNPP substrate solution into 96-well plates in triplicates.
After 30 min of incubation at room temperature (RT), the reaction was
stopped by adding 50 µl of stop solution, and the colorimetric determination
of the product was performed at 405 nm using FlexStation™ 3 Microplate
Reader. Twofold serial dilutions from 0.2 µg/ml ALP standard were made to
prepare a calibration curve. The data were analysed using SoftMax Pro
software. Results were normalized to the total cell number which was
determined by the PicoGreen® assay. ALP activity was expressed in ng
p-nitrophenol produced/30 min/cell.
Scanning electron microscopy (SEM)
To evaluate cell adhesion and ECM production/maturation, SEM analysis
was performed. Cell-seeded scaffolds were washed in PBS 1× and fixed
overnight in 2.5% (v/v) glutaraldehyde solution (Sigma-Aldrich) at 4°C.
Dehydration was achieved by sequential immersion in serial diluted ethanol
solutions of 30, 50, 70, 80, 90, 95 and 100% (v/v) for 15 min each, followed
by critical point drying (AUTOSAMDRI-815, Tousimis). Finally, samples
were sputter-coated with gold (thickness of 30 nm) using a Leica EM
AC600, and examined using a NOVA NANOSEM 230 scanning electron
microscope (Pharmazentrum ZMB, University of Basel). HA scaffolds
without cells were used as negative control.
Gene expression analysis using qPCR
After 3, 7, 14 and 28 days of culture, total RNA was isolated from the
samples using TRIzol (Life Technologies) according to the manufacturer’s
instructions.
RNA extraction
Samples were crushed and 500 µl of cold TRIzol were added to each sample.
100 µl of chloroform were added to the homogenate, and incubated at RT for
3 min. After centrifugation at 12,000 g for 15 min at 4°C, the upper aqueous
phase containing the RNA was collected and precipitated with 250 µl of
isopropanol. To facilitate the precipitation, 2 µl of glycogen (Life
Technologies) were added. Samples were incubated at RT for 10 min, and
centrifuged at 12,000 g for 10 min at 4°C. The washing step was done
with 75% ethanol, and the pellet was air-dried for 10 min before being
resuspended in RNase-free water. The concentration and purity of each sample
were assessed by the absorbance at 260 nm and by the A260/A280 ratio,
respectively. RNA amounts were assessed with a NanoDrop® 2000C (Thermo
Fisher Scientific), and data were analysed with NanoDrop 2000/2000C
software. All samples were diluted to obtain final concentrations of 10 ng/µl.
cDNA synthesis
1 µl of random primers (Promega) was added to 19 µl of RNA (10 ng/µl)
and incubated at 70°C for 10 min to straighten the RNA. 10 µl of reaction
mix was prepared per sample and added to preincubated RNA [0.5 µl
Reverse transcriptase Superscript III RT 200 U/µl, 0.8 nM dNTP mix, 6 µl
5× first-strand buffer, 1 µl DTT and RNase-free water (Life Technologies)].
The mixture was treated as follows: 25°C for 10 min, 48°C for 30 min and
95°C for 5 min (Biometra, T3000 Thermocycler).
Reverse transcriptase polymerase chain reaction (RT-qPCR) assays were
performed to determine the level of mRNA transcripts of the following
genes of interest: ALP, osteocalcin (OC), collagen type I (COL1A1),
vascular endothelial growth factor (VEGF), cluster of differentiation 31
(CD31), endothelial nitric oxide synthase (eNOS) and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) as reference gene. Table 1 shows the
sequences of the oligonucleotides that were used as PCR primers. All
primers were purchased from Microsynth AG and reconstituted with
Nuclease-free water to obtain 100 µM stock solutions.
Briefly, the reaction volume (20 µl) included 12.5 µl FastStart SYBR
Green Master Mix (Roche), 2.5 µl diluted cDNA (10 ng/µl), 2 µl Primers
mix (forward and reverse, 0.375 µM each) and 3 µl Nuclease-free water.
After initial denaturation at 94°C for 5 min, the target genes were amplified
with 45 quantification cycles (Cq) of denaturation at 94°C for 20 s and
Table 1. Oligonucleotide primers for qRT-PCR
Gene symbol Forward primer (5′-3′) Reverse primer (5′-3′)
ALP GAAATCTGTGGGCATTGTGA GCCAACCACTGTACACACCA
OC CAGCGAGGTAGTGAAGAGAC ACTCGTCACAGTCCGGATTG
COL1A1 CGGAGGAGAGTCAGGAAG CAGCAACACAGTTACACAAG
GAPDH TTCCACCCATGGCAAATTCC ACGTACTCAGCGCCAGCATC
VEGF CCCACTGAGGAGTCCAACAT AAATGCTTTCTCCGCTCTGA
CD31 ATTGCAGTGGTTATCATCGGAGTG CTCGTTGTTGGAGTTCAGAAGTGG
eNOS TTTGCCCTTATGGATGTGAAG CGCATCAAAGAAAGCTCACT
8
RESEARCH ARTICLE Biology Open (2018) 7, bio034488. doi:10.1242/bio.034488
B
io
lo
g
y
O
p
en
 by guest on February 13, 2019http://bio.biologists.org/Downloaded from 
annealing at 58°C for 60 s. Afterwards, a dissociation cycle was performed
from 50°C to 99°C (1°C every 5 s for each quantification cycle). The
melting curve for each amplicon was performed to ensure the assay
specificity validation. Real-time PCR reactions were carried out by
rotor-Gene® Q and Corbett devices (Qiagen). Data were analysed with
Rotor-Gene 6000 Series Software and the levels of RNA expression were
calculated according to the 2−ΔΔCq method (Livak and Schmittgen, 2001).
The expression level of each target gene was normalized to GAPDH as
reference gene. The fold changes were calculated using Eqns 1-3 below:
SampleDCq ¼ Cqsample  CqGAPDH ð1Þ
DDCq ¼ SampleDCq ControlDCq ð2Þ
Fold-change of the sample versus control ¼ 2DDCq ð3Þ
Each sample was assessed in three technical replicates for each gene of
interest.
Immunohistochemistry and histological staining
Immunohistochemistry analyses were performed to characterize cellular
morphology, distribution and ECM maturation on HA scaffolds. Cell
morphology was investigated by examining the F-actin cytoskeleton
fluorescently stained with Texas Red [Texas Red-X-Phalloïdin, and the
nucleus stained with DAPI (Invitrogen)]. To detect ECMmaturation, aMAb
Mouse IgG1 anti-Human Osteocalcin (R&D) was used as primary antibody,
and a Goat anti-Mouse IgG (H+L) antibody labelled with Alexa Fluor® 488
(Invitrogen) was used as a secondary antibody. Samples were washed with
1× PBS for 5 min, fixed with 4% (w/v) paraformaldehyde for 10 min, and
rinsed three times with 1× PBS for 3 min each. Permeabilization was carried
out using 0.1% Triton X-100 for 5 min. After washing three times with 1×
PBS, samples were blocked with 5% (w/v) Bovine Serum Albumin solution
(BSA) for 1 h in order to remove unspecific background. The samples were
then incubated with Texas Red-X Phalloïdin diluted in 1% (w/v) BSA
solution with a ratio of 1:500 (13.2 nM) at RT for 20 min. Samples were
rinsed twice with 1% BSA solution for 3 min each, and incubated with
2.5 µg/ml osteocalcin primary antibody at RT for 2 h. After extensive
washing steps, samples were incubated with 5 µg/ml secondary antibody at
RT for 45 min. After further washing steps, samples were incubated with
0.95 µM DAPI at RT for 2 min followed by a final washing step with 1×
PBS. Pictures of entire scaffolds on a glass slide were taken using an
Olympus Laser Confocal Scanning Microscope FV1000D spectral type.
For the histological staining, constructs retrieved at 14 and 28 days of cell
seeding were fixed overnight in 4% paraformaldehyde at 4°C. After fixation,
samples were decalcified by incubation in a solution with 7 % (w/v) EDTA
(7×104 µg/ml) and 10% (w/v) sucrose (105 µg/ml) at 37°C, 5% CO2 on an
orbital shaker for 8-10 days. The solution was changed every 2 days and the
hardness of the scaffold was checked daily. After washing in 1× PBS,
samples were paraffin-embedded (TPC 15DUO, Medite TBS88 Paraffin
embedding system cool unit, Switzerland) and sectioned (7 µm thick) by
means of a microtome (Zeiss HYRAX M55). Paraffin sections were
deparaffinized, hydrated and stained with Hematoxylin and Eosin (H&E)
for nuclei and cytoplasm, respectively (Medite Tissue Stainer COT 20).
Histology samples were observed under an Olympus CKX41 inverted
microscope (n=4 for each condition).
Mechanical testing
Scaffolds immersed in solution (wet condition) were tested by nanoindentation
using the Piuma nanoindenter (Optics11) (n=3–4). The Young’sModulus was
calculated using the data in the unloading curvewith nine unique spots on each
scaffold, making a slope estimate of all data points between 65 and 85% of the
maximum load, and using the Oliver & Pharr model to calculate the efficiency
‘E’. The probe used was 173 N/m and 30.5 µm. For the cell-seeded scaffolds,
differentiation induction medium was used.
In addition, standard compression tests were performed with a
Hydropulser LFV-5-PA/ECD (Walter and Bai AG, Switzerland) under
wet conditions to compare the elastic modulus (MPa) for cell-free and
cell-seeded scaffolds (n=3).
Devitalization/decellularization
After ECM deposition, samples were devitalized to obtain 3D-printed
porous HA scaffolds coated by ECM without cells. Briefly, samples
underwent three freeze and thaw (F/T) cycles in liquid nitrogen and 37°C
water bath (10 min each), respectively. Scaffolds were rinsed in sterile PBS
after each thaw step as well as in double-distilled water after the second thaw
in order to hypotonically lyse remaining cells. To decellularize HA scaffolds
(to eliminate cellular debris), a perfusion-based washing step was added
subsequent to the F/T. The constructs were placed into the bioreactor system
and perfused at 0.47 ml/min in PBS for 30 min at room temperature. To
verify if the perfusion washing step was effectively removing cellular debris,
a DAPI staining was performed and visualized using an inverted
microscope.
CAM assay and MRI assessment
No IACUC approval is necessary when performing experiments in chicken
embryos until embryonic day 14 (ED 14) according to Swiss animal care
guidelines (TSchV, Art. 112). Fertilized Lohman white LSL chicken eggs
(Animalco AG, Staufen AG, Switzerland) were pre-incubated for 3 days at
37°C at a rotation speed of 360°/12 h. On ED 3 the eggs were processed for
in ovo cultivation, which requires the opening of the shell with a drill
(Dremel®, Conrad Electronic AG, Wollerau SZ, Switzerland). 2 ml of
albumen was always removed with a syringe to increase the empty space
under the top of the egg shell. The eggs were stabilized in 60 mm Petri
dishes (Greiner Bio-One GmbH, Frickenhausen, Germany) and the
created holes of the shells were covered with another 60 mm Petri dish
that was fixed with a tape before incubating the eggs at 37°C. On ED 7, the
decellularized HA scaffolds coated with either ECM produced from cells
in proliferation medium or in osteogenic medium were placed on the CAM
in the middle of silicon rings that ensure a flat surface during their
incubation period of 7 days (n=4 for each group with ECM coating). As a
control, ECM-free HA scaffolds were also placed on top of the CAM
(n=6).
Vascularization of the scaffolds by capillaries of the chicken embryo’s
CAM was studied on ED 14 using MRI as previously described (Kivrak
Pfiffner et al., 2014). The eggs were placed onto a custom-built sliding bed
and enveloped by warm water tubing to maintain the temperature of the
chicken embryo in a physiological range. To prevent motion, the chicken
embryo was sedated with five drops of 1:100 M ketamine (Ketasol-100,
Dr E. Graeub AG, Bern BE, Switzerland) dripped onto the CAM surface.
MRI was performed with a 4.7 T/16 cm Bruker PharmaScan small animal
scanner (Bruker BioSpin MRI GmbH, Ettlingen, Germany) equipped with
an actively decoupled two-coil system consisting of a 72 mm bird cage
resonator for excitation and a 20 mm single loop surface coil for reception.
T1-weighted MR images were acquired with a RARE sequence of variable
TR and TE for quantitative T1 and T2 mapping. T1 maps were acquired in
the samples before and after intravenous injection of 0.05 M Gd-DOTA
MRI contrast agent (Dotarem®, Guerbet AG, Zuerich ZH, Switzerland).
The time between Gd-DOTA injection and T1 mapping was kept constant at
25 min. T1 relaxation times were determined in three layers of interest: at the
interface of the scaffold with the CAM (i.e. lower part), in the middle part of
the scaffold, and finally at the surface of the scaffold (i.e. upper part); for
each layer, three ROIs were assessed, resulting in nine ROIs per scaffold.
Perfusion capacity in these ROIs was assessed through changes in the
longitudinal relaxation rate ΔR1 before and after injection of Gd-DOTA,
as the relaxation rate changes with the amount of gadolinium present in
the CAM.
Statistics
The data was analysed with StatView 5.0.1 software. One-way statistical
ANOVAwas conducted to test the significance of differences between cell
numbers at different days, ALP activities or manifold inductions of gene
expression. Pairwise comparison probabilities (p) were calculated using
the Tukey–Kramer HSD post hoc test to evaluate differences between the
groups. P-values<0.0001 were considered significant, except for the
perfusion capacity as assessed with MRI, where P<0.05 was considered
significant and P-values were given for the significantly different groups.
Values are expressed as means±standard deviations.
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